Home About Us Services Industry Report Store Resources Contact us

Global Blood Bags Industry Market Dynamics & Strategic Insights (2023 – 2031)

Published : Dec 2023

Report ID: FMO9694

Pages : 250

Format :

Blood bags are designed for the collection, processing and storage of whole blood and blood components. They help in providing aseptic conditions for the separation of blood components. It acts as a closed system reducing the chances of contamination. Blood bags are made with high molecular weight PVC to ensure better tensile strength and weld strength. Blood bag systems are disposable bio-medical products designed for collection, storage, transportation, and transfusion of human blood and blood-derived products. Disposable plastic blood bags are utilized in hospitals, blood banks, government programs, and non-governmental organizations (NGOs) for collecting, storing, processing, and transporting blood collected during blood donation programs.
Blood bags enable better separation of blood components in a more sterile manner and safer transfusion of components. This has led to increasingly wider use of blood component therapy than whole blood use, thus enabling more effective use of the scarce donor blood that is available. Blood Bags can successfully replace the use of glass bottles for collection storage, transportation and transfusion of blood and blood components since bottles require exhaustive cleaning, rinsing and autoclaving procedures and there are chances of breakage at any stage. Further, use of disposable bags eliminates the possibility of any contamination.
This report focuses on the Blood Bags in global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. In the global blood bag market, Asia Pacific region holds the highest market share of 33% globally and is considered as fastest growing market with CAGR of 11.72%.
At country level U.S, China and India are expected to register significant growth over the forecast period, owing to increasing demand for blood and blood components. The key factors that drive the market include government initiatives and increase in need of blood transfusion in the region. Moreover, prevalence of various diseases, surge in awareness among people, and blood donation campaigns carried out by private and government organizations are anticipated to fuel the demand for disposable blood bags.
The Global Blood Bag market is segmented in to type and by application. In Application segment the market is sub segmented as hospital based and standalone. In this segment hospital based segment holds 62.7% of the global market share by application owing to increasing privatization of healthcare services in countries such as India and China
By type, the Global Blood Bag market is segmented collection bags and transfer bags. In terms of value, collection bags product type segment is estimated to account for over 73.1% market share of the global market by 2016 end. Due to high levels of blood donations around the globe. Growth in awareness regarding blood donation among the locals boosts the growth of blood donations in the developing and underdeveloped regions. Hospital-based blood donation sites are expected to account for the highest revenue during the analysis period, owing to maximum number of blood donation in such facilities.
Some of the key players identified in the global blood bags market report are Grifols S.A., Fresenius Se & Co. Kgaa, Hll Lifecare, Ltd., Haemonetics Corporation, Innvol Medical India Ltd., Neomedic Limited, Macopharma Sa, Poly Medicure Ltd., Span Healthcare Private Limited, and Teleflex. The report also includes identification of company-specific strategies and recent developments, and analysis of the various market players’ specific strengths, weaknesses, opportunities, and threats. In the global blood bag market Grifols S.A., Fresenius Se & Co. Kgaa, Hll Lifecare, Ltd., are the top players and manufacturers of blood bag market.
There are various regulatory bodies actively looking after company rules & regulations for addressing Medical policies. The Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, The French Blood Institute and 4 different National Blood Transfusion services in U.K are some of the key influencing regulatory bodies at global and at regional level.

Scope:

Report Data Market
Forecast 2022 XX million/billion (2022-2032)
CAGR 2022 - 2032%
Analysis Period2022 - 2032
Base Year2021
Forecast Data2022 - 2032
Segments CoveredBy Type, By Application, And by Regions
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled.
Key Segments

By Type

By Applications

Report CoverageMarket Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Frequently Asked Questions

What is the future market value of the ?

The current market value for is expected USD XX million/billion by 2022.

What is the CAGR of the Market?

The is to grow at a CAGR of 5.3% during the forecast by 2032.

What is the Market segment?

On the basis of type, the is segmented into Types.

Who are the key players operating in the ?

The major players operating in the are Company.

Select Licence Type

Single User

US$ 3350

Multi User

US$ 4950

Corporate User

US$ 6950

Excel Datapack

US$ 1100
4adc642e6c5c515ece99cc59baa7e1cf.png

Published Date : Dec 2023 | Formats :

Why Future Market Outlook

100%

Customer
Satisfaction

24x7+

Availability - we are always
there when you need us

200+

Fortune 50 Companies trust
Future Market Outlook

80%

of our reports are exclusive
and first in the industry

100%

more data
and analysis

1000+

reports published
till date